How Has The Transfection Reagents And Equipment Market Size Evolved In Recent Years?
The transfection reagents and equipment market has seen considerable growth due to a variety of factors.
•The market size for transfection reagents and equipment has experienced swift growth in the recent past. Its valuation is expected to rise from $1.58 billion in 2024 to $1.75 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%.
Factors such as increased demand for biomedical research, pharmaceutical advancements, the proliferation of biotechnology applications, the contribution of academic and research institutions, and progress in genetic engineering have contributed to its growth during the historical period.
What Is The Projected Growth Of The Transfection Reagents And Equipment Market?
The transfection reagents and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to experience impressive growth in the forthcoming years, the market size for transfection reagents and equipment is on track to reach "$2.69 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%.
This growth trajectory during the forecast period is credited to advancements in gene therapy, an uptick in bioproduction needs, the emergence of cell-based therapies, research and development in personalised medicine, and global partnerships. Additionally, the forecast period is set to see a focus on primary cell transfection, a shift towards electroporation techniques, the integration of nanotechnology in transfection, rising demand for animal-free transfection reagents, and the melding of automation and high-throughput transfection systems.
What Key Factors and Trends are Driving the Growth of the Transfection Reagents And Equipment Market?
The global increase in cancer patients is anticipated to boost the expansion of the transfection reagents and equipment market. Cancer consists of diseases characterized by abnormal and unregulated cell growth. Transfection reagents, which are widely implemented in cancer research, are used to insert alien genetic material like plasmid DNA or RNA molecules. This can assist researchers in studying various aspects of cancer biology, such as gene expression studies, gene silencing, drug screening, and target validation. For example, the American Cancer Society, a non-profit organization based in the US, registered 20 million new cancer cases and 9.7 million fatalities in 2022 in April 2024. Consequently, the global surge in cancer patients underpins the expansion of the transfection reagents and equipment market.
What are the Market Segments in the Transfection Reagents And Equipment Market?
The transfection reagents and equipment market covered in this report is segmented –
1) By Products: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By Organism: Bacteria, Mammalian Cells, Fungi, Plants, Virus
4) By End User: Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs), Academia, Hospitals, Clinical Labs, Other End Users
Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems, Other Instruments
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits, Other Reagents And Kits
Pre-Book The Transfection Reagents And Equipment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Transfection Reagents And Equipment Market?
In the transfection reagents and equipment market, product innovation is emerging as a primary trend. The strategic focus of top-tier companies in the market is directed towards inventing novel products to maintain their market dominance. For instance, Polyplus-Transfection SA, a renowned biotech firm in France, unveiled an in vivo-jetRNA+ transfection reagent for in vivo mRNA delivery leveraging preformed liposome formulation, in September 2022. This cutting-edge product serves as a highly efficient, scalable gene delivery mechanism capable of funneling mRNA to a variety of tissues and cell types. The reagent also exhibits a good safety profile and high tolerability, which positions it as a potential tool for the creation of novel gene therapies. The ready-to-go design eliminates the necessity for formulation steps and the constant liposome size supports mRNA concentrations that can go from low to high over time. The applications are broad, including prophylactic vaccinations, mRNA treatments for cancer therapy, rare diseases, among others, and gene editing.
Who Are the Key Players in the Transfection Reagents And Equipment Market?
Major companies operating in the transfection reagents and equipment market include:
• Thermo Fisher Scientific Inc.
• Promega Corporation
• Qiagen N.V.
• Bio-Rad Laboratories Inc.
• Maxcyte Inc.
• Lonza Group Ltd.
• Merck KGaA
• Mirus Bio LLC
• OriGene Technologies Inc.
• PromoCell GmbH
• PerkinElmer Inc.
• Agilent Technologies Inc.
• Altogen Biosystems
• Applied Biological Materials Inc.
• Bex Co. Ltd.
• Sartorius AG
• Takara Bio Inc.
• Tecan Trading AG
• Polyplus-transfection SA
• Sigma-Aldrich Corporation
• Hoffmann-La Roche Ltd.
• Transfection Technologies Inc.
• Viromer
• ABM Inc.
• Bio-Techne Corporation
• Biotium Inc.
• Cell Applications Inc.
• chemicell GmbH
• Genlantis
• Biontex Laboratories GmbH
• Boca Scientific Inc.
• Jena Bioscience GmbH
What are the Regional Insights into the Transfection Reagents And Equipment Market?
North America was the largest region in the transfection reagents and equipment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
